https://www.selleckchem.com/products/ly3023414.html compared with other Caucasian populations. The incidence of glaucoma in those with PEX was higher compared with the incidence of glaucoma in those without PEX. To present the case of a family with a novel PRPH2/RDS mutation. A case report. A 44 year old female and her immediate family, including a father and sister who shared her PRPH2/RDS mutation. A 44 year old female presented with exam findings consistent with a butterfly-type pattern dystrophy. A sister had a similar butterfly-type dystrophy, while their father had a severe cone-rod dystrophy. Genetic testing revealed the same novel PRPH2/RDS mutation in all three affected individuals, suggesting that this single mutation can produce at least two disparate retinal disease phenotypes. This case describes a novel p.Y225X nonsense mutation in the PRPH2/RDS gene and demonstrates that it is both pathologic and capable of significant phenotypic variability. This case describes a novel p.Y225X nonsense mutation in the PRPH2/RDS gene and demonstrates that it is both pathologic and capable of significant phenotypic variability. To describe a patient with an unusual presentation of iris metastasis from breast cancer and her response to systemic therapy. Retrospective chart review of one patient. A 57-year-old woman presented with a superonasal translucent vascularized iris stromal mass with fish egg-like structures budding from the surface. High frequency anterior segment ultrasonography demonstrated a solid iris stromal mass measuring 6.0 x 3.3 x 1.9 mm. On optical coherence tomography, the egg-like structures appeared as hyperreflective spheres, some of which were detached from the main iris stromal tumor. Oncologic evaluation revealed metastatic breast cancer involving the brain and lung. She was treated with oral abemaciclib and letrozole, as well as external beam radiotherapy to the brain. The iris mass had completely regressed within 4 months and remained undetect